We are live on ! Find out more
PC

PointState Capital Portfolio holdings

AUM $7.9B
1-Year Est. Return 42.31%
This Fund
S&P 500
This Quarter Est. Return
+14.05%
1 Year Est. Return
+42.31%
3 Year Est. Return
+142.91%
5 Year Est. Return
+261%
10 Year Est. Return
+1,945.58%
AUM
$9.59B
AUM Growth
+$2.64B
Cap. Flow
+$1.86B
Cap. Flow %
19.38%
Top 10 Hldgs %
41.45%
Holding
182
New
66
Increased
33
Reduced
26
Closed
49

Sector Composition

Rank Sector Weight
1 Communication Services 18.19%
2 Energy 11.57%
3 Financials 10.79%
4 Healthcare 10.61%
5 Technology 10.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HQY icon
76
HealthEquity
HQY
$8.71B
$16.9M 0.18%
399,100
+49,100
+14% +$2.17M
AGRO icon
77
Adecoagro
AGRO
$1.4B
$16.6M 0.17%
1,448,700
-36,400
-2% -$428K
CYH icon
78
Community Health Systems
CYH
$382M
$16.6M 0.17%
+1,870,000
New +$14.6M
GLD icon
79
CALL
SPDR Gold Trust
GLD
$131B
$16.6M 0.17%
+139,400
New +$16.2M
I
80
DELISTED
INTELSAT S. A.
I
$15.6M 0.16%
3,750,000
+1,515,645
+68% +$5.71M
SRE icon
81
Sempra
SRE
$58.1B
$15.4M 0.16%
+279,400
New +$14.8M
BLUE
82
DELISTED
bluebird bio
BLUE
$15.3M 0.16%
+12,998
New +$13.3M
MCD icon
83
McDonald's
MCD
$193B
$15.2M 0.16%
+117,400
New +$14.7M
IRTC icon
84
iRhythm Holdings
IRTC
$4.02B
$15.2M 0.16%
+403,700
New +$13.9M
NEE icon
85
NextEra Energy
NEE
$184B
$14.9M 0.16%
+464,400
New +$14.6M
UHS icon
86
Universal Health Services
UHS
$10.2B
$12.4M 0.13%
+100,000
New +$11.8M
IPXL
87
DELISTED
Impax Laboratories, Inc.
IPXL
$12.3M 0.13%
+970,400
New +$11.7M
GBT
88
DELISTED
Global Blood Therapeutics, Inc.
GBT
$11.8M 0.12%
+319,800
New +$8.05M
EXC icon
89
Exelon
EXC
$48.1B
$11.7M 0.12%
+455,930
New +$11.6M
NKTR icon
90
Nektar Therapeutics
NKTR
$2.39B
$10.6M 0.11%
+30,233
New +$6.8M
ONCE
91
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$10.4M 0.11%
+195,469
New +$11.6M
ACIU icon
92
AC Immune
ACIU
$231M
$10.4M 0.11%
1,000,000
+225,000
+29% +$2.76M
RF icon
93
Regions Financial
RF
$26.4B
$10.2M 0.11%
702,600
-2,461,900
-78% -$36.3M
AEE icon
94
Ameren
AEE
$30.4B
$10M 0.1%
+183,500
New +$9.82M
AEP icon
95
American Electric Power
AEP
$70.4B
$9.73M 0.1%
+145,000
New +$9.39M
ALXN
96
DELISTED
Alexion Pharmaceuticals
ALXN
$9.66M 0.1%
79,700
-1,029,250
-93% -$133M
AGN
97
PUT
DELISTED
Allergan plc
AGN
$9.56M 0.1%
+40,000
New +$9.31M
BWXT icon
98
BWX Technologies
BWXT
$14.4B
$9.52M 0.1%
+200,000
New +$8.73M
XLE icon
99
State Street Energy Select Sector SPDR ETF
XLE
$39B
$9.07M 0.09%
+259,600
New +$9.38M
XLE icon
100
CALL
State Street Energy Select Sector SPDR ETF
XLE
$39B
$8.98M 0.09%
+257,000
New +$9.29M

Similar funds

PointState Capital's Q1 2017 Portfolio in Review

As of Q1 2017, PointState Capital held 182 positions worth $9.59B, up 38% from $6.95B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

PointState Capital deployed $1.86B of net new capital in Q1 2017, opening 66 new positions and adding to 33 existing holdings. Its largest new stake was DuPont de Nemours: 3,776,539 shares worth $608M.

By sector, the portfolio is most concentrated in Communication Services at 18% of assets, up from 7.4% a quarter earlier, followed by Energy and Financials.

On the sell side, the largest reduction was LyondellBasell Industries, an estimated $448M trimmed.

  • PointState Capital's largest Q1 2017 buy was DuPont de Nemours: 3,776,539 shares worth $608M.
  • PointState Capital added most to Meta Platforms (Facebook) in Q1 2017, an estimated $343M increase.
  • PointState Capital's biggest Q1 2017 reduction was LyondellBasell Industries, cutting an estimated $448M.
  • PointState Capital fully exited KeyCorp in Q1 2017, selling an estimated $188M.
  • PointState Capital's ten largest holdings make up 41% of its $9.59B portfolio in Q1 2017.
  • PointState Capital opened 66 new positions and closed 49 in Q1 2017.
  • PointState Capital's portfolio value rose 38% quarter-over-quarter to $9.59B.

Based on PointState Capital's 13F filing for Q1 2017, filed 15 May 2017.